Interaction Effects of Vitamin D Supplementation and Aerobic Exercises on Balance and Physical Performance in Children With Down Syndrome
1 other identifier
interventional
59
1 country
1
Brief Summary
Objective: To investigate the interaction effects of vitamin D supplementation and aerobic exercises on balance control and physical performance in children with Down syndrome (DS). Methods: Forty-five children with DS ranging in age from 8 to 12 years will be selected and will participate in this study. They will be assigned randomly using sealed envelopes into three equal groups (A, B and C). Group A will consist of 15 children and will receive the conventional physical therapy program (CPTP) only. Group B will consist of 15 children and will receive the CPTP plus the aerobic exercises. Group C also will consist of 15 children and will receive the CPTP, the aerobic exercises and Vitamin D supplementation in the form of an oral dose of vitamin D3 1000 IU (Cholecalciferol). The program of treatment will be 3 days/week for 12 weeks. Evaluation of balance by using the biodex balance system and physical performance by using the six-minute walk test (6MWT) will be conducted at baseline and after 12 weeks of the treatment program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2018
CompletedFirst Submitted
Initial submission to the registry
December 17, 2018
CompletedFirst Posted
Study publicly available on registry
December 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2019
CompletedDecember 2, 2019
November 1, 2019
3 months
December 17, 2018
November 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Balance
Balance assessment will be conducted by using the Biodex Stability System (BSS; Biodex, Inc, Shirley, NY) that enables objective assessment of balance.
This outcome will be measured for each child before the beginning of treatment program and immediately after 12 weeks of the treatment program.
Physical performance
Physical performance will be evaluated using the six-minute walk test (6MWT).
This outcome will be measured for each child before the beginning of treatment program and immediately after 12 weeks of the treatment program.
Study Arms (3)
Physical therapy group
ACTIVE COMPARATORGroup A will consist of 15 children and will receive the conventional physical therapy program only. This group will be used to compare the results of the other two groups.
Physical therapy and aerobic exercises group
EXPERIMENTALGroup B will consist of 15 children and will receive the conventional physical therapy program and aerobic exercises.
Physical therapy, aerobic exercises and vitamin D group
EXPERIMENTALGroup C will consist of 15 children and will receive the conventional physical therapy program, aerobic exercises and an oral daily dose of vitamin D3 1000 IU (Cholecalciferol) .
Interventions
Aerobic exercises: Children in groups B and C will receive aerobic exercises in the form of bicycle ergometer and treadmill training for 15 min 3 days/week for 12 weeks. The procedure and goals of exercise will be explained to all children before starting the exercise program. The child will stop exercising immediately if he feels pain, fainting or shortness of breath. Vitamin D supplementation: Children in group C only will receive vitamin D supplementation in the form of an oral daily dose of vitamin D3 1000 IU (Cholecalciferol) for 12 weeks.
Eligibility Criteria
You may qualify if:
- Children with DS who can stand and walk independently
- Children with 25 (OH) vitamin D levels of 16 ng/ml or less
- Children who are not consuming estrogens, steroids or other medications that could interfere with vitamin D metabolism
- The absence of visual and hearing impairments that could interfere with testing and training protocols
- Children with mild intellectual disabilities and were capable of understanding visual and verbal instructions.
You may not qualify if:
- Medical conditions that will severely limit a child's participation in the study as cardiac problems.
- Musculoskeletal deformities of the lower limbs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Physical Therapy - Cairo University
Cairo, Giza Governorate, 12613, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcomes assessor will be blinded to which each child allocated to any one of the three arms.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 17, 2018
First Posted
December 21, 2018
Study Start
December 2, 2018
Primary Completion
March 2, 2019
Study Completion
March 2, 2019
Last Updated
December 2, 2019
Record last verified: 2019-11